ISMP Medication Safety Alert!®

Community/Ambulatory

A valuable resource to reduce medication error risk in outpatient settings

The ISMP Medication Safety Alert!®Community/Ambulatory Care is a 4-5 page digital newsletter, published monthly for healthcare practitioners in ambulatory settings, including community pharmacies, outpatient clinics, physician offices, and state institutions.

Who reads this newsletter?

  • Community/ambulatory care pharmacists
  • Pharmacy managers and executives
  • Pharmacy technicians and other pharmacy staff
  • Physicians and nurses in ambulatory practice
  • Anyone concerned with medication safety

Subscription Information

  • Twelve (12) issues per year
  • One-year subscription rate: $65.00
  • Distributed via email on a monthly basis
  • Special pricing for group purchases; contact ISMP 
  • One-year subscriptions start from the date of purchase. You will be granted access to issues released after date of purchase for one year. This does not include access to back issues.
One-year subscription: $65.00

Browse Issues

This month's main topic: Get the Mix Right! Improve Processes to Reduce the Risk of Dispensing Medications that Have not Been Reconstituted Accurately
This month's main topic: QuarterWatch™ (2016 Quarter 3 Data): Depression and Suicidal Behaviors: Exploring the Link with Certain Drugs
This month's main topic: QuarterWatch™ (2016 Quarter 2 Data): Signals for Liver Failure with Hepatitis C Drugs and Insomnia with a Variety of Drugs
This month's main topic: QuarterWatch™ (2016 Quarter 1 Data): Lessons Learned from Withdrawal of Zecuity Ppatch and Patient Difficulties Using Tanzeum pen
This month's main topic: QuarterWatch™ Latest Edition: Cancer Risks with Biological Products for Psoriasis and Sudden Hearing Loss with Tadalafil and Sildenafil
In this month's issue: Government and Industry Fail to Protect the Public when They Suggest “Carefully Following Instructions” is Enough to Prevent Vaccine Errors
This month's main topic: QuarterWatch™ 2015 Quarter 1 and 2 Report: Focus on a New Sleep Medication, Changing Opioid Use, and New Diabetes Medications